If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2007 Ph.D., Department of Life Sciences, National Taiwan Normal University
  • 1999 Bachelor, Department of Nursing, College of Medicine, National Cheng-Kung University

Experience

  • 2017- Associate Professor, Graduate Institute of Pharmacognosy, Taipei Medical University
  • 2016-2017 Assistant Professor, Ph.D. Program in Biotechnology Research and Development, Taipei Medical University
  • 2010-2017 Assistant Professor, Graduate Institute of Pharmacognosy, Taipei Medical University
  • 2007-2009 Postdoctoral Fellow, Department of Pharmacology, College of Medicine, National Cheng-Kung University.
  • 2009-2010 Postdoctoral Fellow, Genomics Research Center, Academia Sinica

Awards

  • 2011李鎮源教授醫學研究青年學者獎

Research Interests

  • Cancer epigenetic study
  • Tumor biology
  • Anti-cancer materials
  • methods development

URL

Fingerprint Dive into the research topics where Ruo-Kai Lin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Development of Breast Cancer Early Detection and Post-Treatment Smart Healthcare Tracking Platform

Lin, R.

6/1/195/1/20

Project: A - Government Institutionb - Ministry of Science and Technology

Study of Novel Genes Regulated by Aberrant Dna Methylation and Application in Colon Cancer Treatment

Lin, R.

8/1/177/31/18

Project: A - Government Institutionb - Ministry of Science and Technology

Study of Novel Genes Regulated by Aberrant DNA Methylation and Application in Colon Cancer Treatment

Lin, R.

8/1/167/31/17

Project: A - Government Institutionb - Ministry of Science and Technology

Study of Novel Genes Regulated by Aberrant DNA Methylation and Application in Colon Cancer Treatment

Lin, R. & Ho, Y.

8/1/157/31/16

Project: A - Government Institutionb - Ministry of Science and Technology

Research Output

  • 1386 Citations
  • 18 h-Index
  • 28 Article

Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction

Chang, S. C., Liew, P. L., Ansar, M., Lin, S. Y., Wang, S. C., Hung, C. S., Chen, J. Y., Jain, S. & Lin, R. K., May 12 2020, In : Clinical Epigenetics. 12, 1, 67.

Research output: Contribution to journalArticle

Open Access
  • 1 Citation (Scopus)

    SMAD3 hypomethylation as a biomarker for early prediction of colorectal cancer

    Ansar, M., Wang, C. J., Wang, Y. H., Shen, T. H., Hung, C. S., Chang, S. C. & Lin, R. K., Oct 1 2020, In : International journal of molecular sciences. 21, 19, p. 1-19 19 p., 7395.

    Research output: Contribution to journalArticle

    Open Access

    Polysaccharides obtained from mycelia of cordyceps militaris attenuated doxorubicin-induced cytotoxic effects in chemotherapy

    Lin, R. K., Choong, C. Y., Hsu, W. H., Tai, C. J. & Tai, C. J., Jun 2019, In : African Health Sciences. 19, 2, p. 2156-2163 8 p.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Citation (Scopus)

    Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target

    Hung, C. S., Wang, S. C., Yen, Y. T., Lee, T. H., Wen, W. C. & Lin, R. K., Oct 10 2018, In : International Journal of Molecular Sciences. 19, 10

    Research output: Contribution to journalArticle

  • 9 Citations (Scopus)

    Bioactive constituents from the termite nest-derived medicinal fungus Xylaria nigripes

    Chang, J. C., Hsiao, G., Lin, R. K., Kuo, Y. H., Ju, Y. M. & Lee, T. H., Jan 27 2017, In : Journal of Natural Products. 80, 1, p. 38-44 7 p.

    Research output: Contribution to journalArticle

  • 19 Citations (Scopus)